Story excerpt provided by Dayton Business Journal.
Written by Tristan Navera.
A bio-tech startup is quickly gathering the venture capital it needs to begin the next stages of its growth, which will mean an investment in Dayton.
Iscemia Care, founded in Cincinnati, is finishing out its latest round of clinical validation — putting it one clinical trial away from entering the market. Now the startup is preparing for its next steps to respond to that, which will bring it to Dayton. It markets a blood test for timely diagnosis and treatment of strokes.
Click here to read the complete article.
Originally published July 29, 2016.